Form 4 for ZBH Zimmer Biomet
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-03 · accession 0001062993-22-023419 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-06 | 2022-12-03 | ZBH | Tornos Ivan | COO | F - Tax | $122.76 | -1,784 | 15.1K | -11% | -$219.0K |
| DM | 2022-12-06 | 2022-12-03 | ZBH | Tornos Ivan | COO | M - OptEx | $0.00 | +3,648 | 15.9K | +30% | $0 |
| DM | 2022-12-06 | 2022-12-03 | ZBH | Tornos Ivan | COO | M - OptEx | $0.00 | -3,648 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-03 | F | D | 462 | $122.76 | 14,370 | D | — | — | (F2) Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
| 2 | Common | Common Stock | 2022-12-03 | F | D | 453 | $122.76 | 13,878 | D | — | — | (F2) Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
| 3 | Common | Common Stock | 2022-12-03 | F | D | 869 | $122.76 | 15,072 | D | — | — | (F2) Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
| 4 | Common | Common Stock | 2022-12-03 | M | A | 1,123 | $0.00 | 14,331 | D | — | — | (F1) Includes 203 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan since December 7, 2021. |
| 5 | Common | Common Stock | 2022-12-03 | M | A | 954 | $0.00 | 14,832 | D | — | — | |
| 6 | Common | Common Stock | 2022-12-03 | M | A | 1,571 | $0.00 | 15,941 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2022-12-03 | M | D | 954 | $0.00 | 0 | D | — · 2022-12-03 to — | 954 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. (F4) On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. |
| 8 | Derivative | Restricted Stock Units | 2022-12-03 | M | D | 1,571 | $0.00 | 0 | D | — · 2022-12-03 to — | 1,571 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. (F4) On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. |
| 9 | Derivative | Restricted Stock Units | 2022-12-03 | M | D | 1,123 | $0.00 | 0 | D | — · 2022-12-03 to — | 1,123 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. (F4) On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. |